Literature DB >> 25130392

Serum Cytokine Levels in Behçet's Disease.

Zeynep Meltem Akkurt1, Mehtap Bozkurt2, Derya Uçmak1, Hatice Yüksel3, Haydar Uçak1, Bilal Sula1, Zeynep Gürsel Özkurt4, Mehmet Yildiz2, Dicle Akdeniz2, Mustafa Arica1.   

Abstract

BACKGROUND: The aim of this study is to investigate and compare the serum levels of various cytokines in patients with Behçet's Disease and healthy controls.
METHODS: Thirty-five patients with Behçet's disease and 29 age and sex-matched healthy controls were included in the study. The patients were separated into groups with active and inactive disease. Serum IL-2, IL-6, IL-8, IL-10, IL-17A, and IFN-γ levels were determined using the enzyme-linked immunosorbent assay method. Cytokine levels of the two patient groups and healthy controls were compared using SPSS 15.0.
RESULTS: Ten patients with active disease and 25 patients with inactive disease were present. Serum IL-8 levels of active BD patients were higher compared to inactive patients (P = 0.048) and healthy controls (P = 0.02). IL-8 levels were correlated with the duration of symptoms (r = 0.490, P = 0.003) and time passed since diagnosis (r = 0.579, P ˂ 0.001).
CONCLUSION: Behçet's disease involves complex interactions of cells of the immune system, mainly T lymphocytes and neutrophils. Further studies on the cytokine profile in Behçet's disease will aid in elucidation of its pathogenesis.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Behçet's disease; interleukin-8

Mesh:

Substances:

Year:  2014        PMID: 25130392      PMCID: PMC6807172          DOI: 10.1002/jcla.21772

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  24 in total

1.  IL-17A has an important role in the acute attacks of Behçet's disease.

Authors:  Nurten Sayin Ekinci; Erkan Alpsoy; Ayse Akman Karakas; Senem Buyukkara Yilmaz; Olcay Yegin
Journal:  J Invest Dermatol       Date:  2010-05-06       Impact factor: 8.551

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  Regulation of TH17 and regulatory T cells in patients with Behçet disease.

Authors:  Haner Direskeneli; Hiroyuki Fujita; Cezmi A Akdis
Journal:  J Allergy Clin Immunol       Date:  2011-09       Impact factor: 10.793

4.  Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.

Authors:  J L Mege; N Dilsen; V Sanguedolce; A Gul; P Bongrand; H Roux; L Ocal; M Inanç; C Capo
Journal:  J Rheumatol       Date:  1993-09       Impact factor: 4.666

5.  Interactions between IL17A, IL23R, and STAT4 polymorphisms confer susceptibility to intestinal Behcet's disease in Korean population.

Authors:  Eun Soo Kim; Seung Won Kim; Chang Mo Moon; Jae Jun Park; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  Life Sci       Date:  2012-03-27       Impact factor: 5.037

6.  Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A.

Authors:  Wei Chi; Peizeng Yang; Xuefei Zhu; Yuqin Wang; Lina Chen; Xiangkun Huang; Xiaoli Liu
Journal:  Mol Vis       Date:  2010-05-19       Impact factor: 2.367

7.  Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.

Authors:  Wei Chi; Xuefei Zhu; Peizeng Yang; Xiaoli Liu; Xiaomin Lin; Hongyan Zhou; Xiangkun Huang; Aize Kijlstra
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07       Impact factor: 4.799

8.  Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.

Authors:  Selda Pelin Kartal Durmazlar; Gul Bahar Ulkar; Fatma Eskioglu; Semih Tatlican; Ali Mert; Ahmet Akgul
Journal:  Int J Dermatol       Date:  2009-03       Impact factor: 2.736

9.  Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.

Authors:  Sunao Sugita; Yuko Kawazoe; Ayano Imai; Yukiko Yamada; Shintaro Horie; Manabu Mochizuki
Journal:  Arthritis Res Ther       Date:  2012-05-01       Impact factor: 5.156

10.  Mean platelet volume in ocular Behçet's disease.

Authors:  Fatih Mehmet Türkcü; Abdullah Kürşat Cingü; Harun Yüksel; Yasin Cınar; Meltem Akkurt; Muhammed Sahin; Zeynep Ozkurt; Alparslan Sahin; Ihsan Caça
Journal:  ScientificWorldJournal       Date:  2013-10-22
View more
  6 in total

1.  Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.

Authors:  Fatmazohra Djaballah-Ider; Zineb Djeraba; Mourad Chemli; Nadjiba Dammene-Debbihe; Doulkifly Lounis; Houda Belguendouz; Yanis Medour; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-03-29       Impact factor: 4.473

2.  Association between MEFV Mutations M694V and M680I and Behçet's Disease: A Meta-Analysis.

Authors:  Ziyan Wu; Shulan Zhang; Jing Li; Si Chen; Ping Li; Fei Sun; Xiaoting Wen; Wenjie Zheng; Fengchun Zhang; Yongzhe Li
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

3.  Behçet's: A Disease or a Syndrome? Answer from an Expression Profiling Study.

Authors:  Ali Kemal Oğuz; Seda Taşır Yılmaz; Çağdaş Şahap Oygür; Tuba Çandar; Irmak Sayın; Sibel Serin Kılıçoğlu; İhsan Ergün; Aşkın Ateş; Hilal Özdağ; Nejat Akar
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

Review 4.  Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future.

Authors:  Fahd Adeeb; Austin G Stack; Alexander D Fraser
Journal:  Int J Rheumatol       Date:  2017-09-10

5.  Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease.

Authors:  Martina Bonacini; Alessandra Soriano; Alessandro Zerbini; Eleonora Calò; Luca Cimino; Francesco Muratore; Luigi Fontana; Luca Braglia; Maria Parmeggiani; Carlo Salvarani; Stefania Croci
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

6.  Pharmacological Inactivation of Src Family Kinases Inhibits LPS-Induced TNF-α Production in PBMC of Patients with Behçet's Disease.

Authors:  Sevgi Irtegun; Gulsum Pektanc; Zeynep M Akkurt; Mehtap Bozkurt; Fatih M Turkcu; Sevgi Kalkanli-Tas
Journal:  Mediators Inflamm       Date:  2016-06-30       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.